Article citationsMore>>

Haroche, J., Amoura, Z., Charlotte, F., Salvatierra, J., Wechsler, B., Graux, C., Brousse, N. and Piette, J.C. (2008) Imatinib Mesylate for Platelet-Derived Growth Factor Receptor-Beta-Positive Erdheim-Chester Histiocytosis. Blood, 111, 5413-5415.
https://doi.org/10.1182/blood-2008-03-148304

has been cited by the following article:

• TITLE: Thirty-Four Months Control of Frail Patient with Multisystemic Affection Proved Erdheim Chester Disease: A Case Report

  AUTHORS: Emad Mohsen Barsoum, Fiby Samir Boules, May Gamal Ashour, Mohsen Samy Barsoum

  KEYWORDS: Erdheim-Chester Disease, Histiocytoses, Non-Langerhans Cell Histiocytoses

  JOURNAL NAME: Journal of Cancer Therapy, Vol.12 No.12, December 13, 2021

  ABSTRACT: Erdheim-Chester disease (ECD) is a rare non-Langerhans form of histiocytosis characterized by multisystemic involvement. We report a case of a 51-year-old male patient treated with pegylated IFN-α in a monthly schedule with low-dose prednisolone and achieved 34 months of control with minimal side effects.